Maropitant citrate for treatment of ulcerative dermatitis in mice with a C57BL/6 background

Journal of the American Association for Laboratory Animal Science

Volumn 50, Issue 2, 2011, Pages 221-226

  Williams Fritze, Misty J ^a   Carlson Scholz, Jodi A ^a   Zeiss, Caroline ^a   Deng, Yanhong ^b   Wilson, Steven R ^a   Franklin, Rebekah ^a   Smith, Peter C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAROPITANT; MAROPITANT CITRATE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; SUBSTANCE P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; DRUG EFFICACY; MOUSE; NONHUMAN; PRURITUS; PYODERMA GANGRENOSUM; RECEPTOR BINDING; SCRATCHING;

ANIMALS; ANTIPRURITICS; DERMATITIS; FEMALE; MALE; MICE; MICE, INBRED C57BL; PRURITUS; QUINUCLIDINES; RECEPTORS, NEUROKININ-1; RODENT DISEASES; SKIN ULCER; SUBSTANCE P;

ANIMALIA; MURINAE; MUS;

EID: 79953813215     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Andoh T, Nagasawa T, Satoh M, Kuraishi Y. 1998. Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice. J Pharmacol Exp Ther 286:1140-1145. (Pubitemid 29135521)
2. Conder GA, Sedlacek HS, Boucher JF, Clemence RG. 2008. Efficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in 2 randomized clinical trials for prevention of vomiting due to motion sickness in dogs. J Vet Pharmacol Ther 31:528-532.
3. Dawson DV, Whitmore SP, Bresnahan JF. 1986. Genetic control of susceptibility to mite-associated ulcerative dermatitis. Lab Anim Sci 36:262-267.
4. de la Puente-Redondo V, Tingley FD 3rd, Schneider RP, Hickman MA. 2007. The neurokinin 1 antagonist activity of maropitant, an antiemetic drug for dogs, in a gerbil model. J Vet Pharmacol Ther 30:281-287. (Pubitemid 47024874)
5. de la Puente-Redondo VA, Siedek EM, Benchaoui HA, Tilt N, Rowan TG, Clemence RG. 2007. The antiemetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in europe. J Small Anim Pract 48:93-98. (Pubitemid 46208815)
6. de la Puente-Redondo VA, Tilt N, Rowan TG, Clemence RG. 2007. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs. Am J Vet Res 68:48-56. (Pubitemid 46157596)
7. Fox JG, Niemi SM, Murphy JC, Quimby FW. 1977. Ulcerative dermatitis in the rat. Lab Anim Sci 27:671-678.
8. Hickman MA, Cox SR, Mahabir S, Miskell C, Lin J, Bunger A, McCall RB. 2008. Safety, pharmacokinetics, and use of the novel NK1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats. J Vet Pharmacol Ther 31:220-229. (Pubitemid 351677395)
9. Hosokawa C, Takeuchi S, Furue M. 2009. Severity scores, itch scores and plasma substance P levels in atopic dermatitis treated with standard topical therapy with oral olopatadine hydrochloride. J Dermatol 36:185-190.
10. Inagaki N, Shiraishi N, Igeta K, Nagao M, Kim JF, Chikumoto T, Itoh T, Katoh H, Tanaka H, Nagai H. 2010. Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus. Eur J Pharmacol 626:283-289.
11. Itah R, Gitelman I, Davis C. 2004. A replacement for methoxyflurane (metofane) in open-circuit anaesthesia. Lab Anim 38:280-285. (Pubitemid 38962077)
12. Kastenmayer RJ, Fain MA, Perdue KA. 2006. A retrospective study of idiopathic ulcerative dermatitis in mice with a C57BL/6 background. J Am Assoc Lab Anim Sci 45:8-12. (Pubitemid 46277582)
13. Kawana S, Liang Z, Nagano M, Suzuki H. 2006. Role of substance P in stress-derived degranulation of dermal mast cells in mice. J Dermatol Sci 42:47-54. (Pubitemid 43384129)
14. Lawson GW, Sato A, Fairbanks LA, Lawson PT. 2005. Vitamin E as a treatment for ulcerative dermatitis in C57BL/6 mice and strains with a C57BL/6 background. Contemp Top Lab Anim Sci 44:18-21. (Pubitemid 41542213)
15. Mufford T, Richardson L. 2009. Nail trims versus the previous standard of care for treatment of mice with ulcerative dermatitis. J Am Assoc Lab Anim Sci 48:546.
16. Ohmura T, Hayashi T, Satoh Y, Konomi A, Jung B, Satoh H. 2004. Involvement of substance P in scratching behaviour in an atopic dermatitis model. Eur J Pharmacol 491:191-194. (Pubitemid 38609477)
17. Ohmura T, Tsunenari I, Hayashi T, Satoh Y, Konomi A, Nanri H, Kawachi M, Morikawa M, Kadota T, Satoh H. 2004. Role of substance P in an NC/Nga mouse model of atopic dermatitis-like disease. Int Arch Allergy Immunol 133:389-397. (Pubitemid 38490218)
18. Paus R, Schmelz M, Biro T, Steinhoff M. 2006. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 116:1174-1186.
19. Percy DH, Barthold SW. 2007. Pathology of laboratory rodents and rabbits, 3rd ed. Ames (IA): Blackwell Publishing.
20. Perkins SN, Hursting SD, Phang JM, Haines DC. 1998. Calorie restriction reduces ulcerative dermatitis and infection-related mortality in p53-deficient and wildtype mice. J Invest Dermatol 111:292-296. (Pubitemid 28354718)
21. Ramsey DS, Kincaid K, Watkins JA, Boucher JF, Conder GA, Eagleson JS, Clemence RG. 2008. Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs. J Vet Pharmacol Ther 31:538-543.
22. Seta S, Buttrey P. 2009. A simplified method for the treatment of mouse dermatitis. J Am Assoc Lab Anim Sci 48:608.
23. Sundberg JP, editor. 1994. Handbook of mouse mutations with skin and hair abnormalities: animal models and biomedical tools. Boca Raton (FL): CRC Press.
24. Sundqvist M, Kristensson E, Adolfsson R, Leffler A, Ahlstedt I, Engberg S, Drmota T, Sigfridsson K, Jussila R, de Verdier J, Noven A, Johansson A, Pahlman I, von Mentzer B, Lindstrom E. 2007. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists. Eur J Pharmacol 577:78-86. (Pubitemid 47632535)